H.C. Wainwright Reaffirms Buy Rating for Legend Biotech (LEGN)

On April 20, H.C. Wainwright maintained its Buy standing for Legend Biotech Corp. (NASDAQ:LEGN). The steadfast has projected a people terms of $50, which yields much than 109% imaginable upside for investors. It highlighted the company’s CAR-T therapies and attributed its bullish presumption of the banal to the ongoing advancement related to those programs. It noted that the proceedings information for vivo CD19/CD20 CAR-T volition beryllium revealed soon.

Tonhom1009/Shutterstock.com

The steadfast besides reflected connected the management’s beardown denotation of captious aesculapian gathering readouts, which look to beryllium imminent successful the foreseeable future. These subordinate to the preliminary dosages fixed to patients during past summer, starring to 6 months of information for patients who person undergone the longest treatments.

H.C. Wainwright besides acknowledged the continued spot shown by the CARVYKTI physics bid publication during the entirety of the archetypal quarter. With favorable operational momentum witnessed from January done April, the steadfast labelled the IQVIA medicine information oscillation arsenic specified outer noise. Such momentum is successful enactment with the company’s 64% topline growth, exceeding $1 cardinal during the anterior 12 months.

Legend Biotech Corp. (NASDAQ:LEGN) is simply a commercial-stage biopharmaceutical institution that develops innovative therapies. Being an end-to-end compartment therapy company, they absorption connected medicine for superior diseases specified arsenic hematologic malignancies and coagulated tumors.

While we admit the imaginable of LEGN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.